Cargando…
Prokaryotic expression of MLAA-34 and generation of a novel human ScFv against MLAA-34 by phage display technology
MLAA-34 is a newly identified monocytic leukemia-associated antigen that is overexpressed in acute monocytic leukemia specifically, thus providing a novel target for the therapy of acute monocytic leukemia. In this study, we first expressed MLAA-34 protein in Escherichia coli (E.coli) BL21 (DE3) cel...
Autores principales: | Zhang, Yang, Zhang, Pengyu, He, Aili, Yang, Yun, Wang, Jianli, Zhang, Hui, Zhang, Wanggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503596/ https://www.ncbi.nlm.nih.gov/pubmed/28388565 http://dx.doi.org/10.18632/oncotarget.16590 |
Ejemplares similares
-
Leukemia-associated gene MLAA-34 reduces arsenic trioxide-induced apoptosis in HeLa cells via activation of the Wnt/β-catenin signaling pathway
por: Zhang, Pengyu, et al.
Publicado: (2017) -
MLAA-34 knockdown shows enhanced antitumor activity via JAK2/STAT3 signaling pathway in acute monocytic leukemia
por: Lei, Bo, et al.
Publicado: (2020) -
Preliminary evaluation of the MLAA algorithm with the Philips Ingenuity PET/MR
por: Lougovski, Alexandr, et al.
Publicado: (2014) -
PET/MR: improvement of the UTE μ-maps using modified MLAA
por: Benoit, Didier, et al.
Publicado: (2015) -
Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments
por: Nannini, Francesco, et al.
Publicado: (2020)